The interaction of soluble human complement receptor type 1 (sCR1, BRL55730) with human complement component C4

Area of Science:

• Immunology
• Biochemistry

Background:

• Human complement receptor 1 (CR1) regulates the complement system, acting as a cofactor for Factor I in C3b and C4b proteolysis.
• Soluble CR1 (sCR1) is a therapeutic candidate for suppressing complement-mediated tissue damage.
• CR1 plays a role in immune complex processing and clearance.

Purpose of the Study:

• To establish an assay for exploring sCR1 binding to C4 isotypes and fragments.
• To investigate the binding characteristics of sCR1 to C4A and C4B.
• To assess the implications of sCR1 binding preferences for immune complex diseases.

Main Methods:

• Development of a microtitre plate assay.
• Utilizing radiolabeled 125I-sCR1 for binding studies.
• Investigating binding under varying pH and ionic strength conditions.

Main Results:

• Specific binding of 125I-sCR1 to C4b and ammonia-treated C4 was demonstrated.
• sCR1 binding to ammonia-treated C4 was dependent on pH and ionic strength.
• sCR1 exhibited a twofold greater binding affinity for ammonia-treated C4A compared to C4B at physiological ionic strength.

Conclusions:

• sCR1 specifically binds to C4 fragments, with a notable preference for the C4A isotype.
• The observed binding preference has potential implications for the clinical association between immune complex diseases and C4A null alleles.
• This study provides a foundation for further research into sCR1's therapeutic potential in complement-mediated disorders.